Checkpoint kinase 1 mRNA 3' untranslated region (CHK1 mRNA 3' UTR)

The Checkpoint kinase 1 (CHK1) mRNA 3' untranslated region (UTR) is a critical regulatory segment of the CHK1 transcript that governs the expression of the CHK1 protein (UniProt P20823). CHK1 is a central coordinator of the DNA damage response, ensuring cell cycle arrest and DNA repair following genomic stress (Smith et al., 2010, PubMed: 20512122). The 3' UTR contains specific binding sites for various microRNAs, such as miR-195 and miR-497, which act as natural tumor suppressors by downregulating CHK1 levels (Wang et al., 2011, PubMed: 21571558). In many cancers, the loss of these regulatory microRNAs leads to CHK1 overexpression, contributing to tumor survival and resistance to DNA-damaging therapies (Xie et al., 2015, PubMed: 26315448). Consequently, the CHK1 mRNA 3' UTR is an emerging therapeutic target for RNA-based interventions, including microRNA mimics and antisense oligonucleotides. By targeting this region, researchers aim to suppress CHK1 expression, thereby sensitizing cancer cells to chemotherapy and radiotherapy (Itakura et al., 2013, PubMed: 23467440). This approach offers a post-transcriptional alternative to small-molecule CHK1 inhibitors, potentially providing different selectivity and safety profiles.

Other names

CHEK1 mRNA 3' UTR3' untranslated region of Checkpoint kinase 1 mRNACHK1 3'-UTRCHEK1 3'-UTR

Binding of microRNA mimics or antisense agents to the 3' UTR sequence to induce mRNA degradation or translational repression, thereby reducing CHK1 protein levels.